Fundraising Fox

ByHeart

New York, US · Founded 2017 · Delaware corporation · 5 known investors

byheart.com ↗

ByHeart is an infant formula company navigating an FDA return-to-market process following a product outbreak investigation. The page addresses regulatory findings, corrective actions, and manufacturing controls rather than describing the full product line.

ConsumerDirect to ConsumerFoodTechHealthtech

Founders & leadership

ByHeart was founded in 2017 by Mia B. Funt, Ron Belldegrun, and Mia Funt.

MB
Mia B. FuntCo-founder
RB
Ron BelldegrunCo-founder
MFMia Funt
Mia FuntinFounder
GK
Georg Krause-VilmarExecutive
NM
Niall MullaneExecutive

Board

ASAmy Schulman
Amy SchulmaninBoard directorManaging Partner at Polaris Partners
HZHemi Zucker
Hemi ZuckerinBoard MemberManaging Partner at OCV Partners
GO
Guy OranimBoard director
ABArie Belldegrun
Arie Belldegrunin𝕏Board directorFounder and Senior Managing Director at Vida Ventures
AL
Anton LinderumBoard director
JKJoshua Kazam
Joshua KazamBoard directorCo-Founder and Director at Vida Ventures
RW
Raphael WallanderBoard director

Investors · 5

Evolution VC PartnersNew York
OCV PartnersLos Angeles
Polaris PartnersreportedBoston · $500K – $5Mvia Amy Schulman · board
Red Sea VenturesreportedNew York · $300K – $1M
Vida VenturesreportedLos Angelesvia Arie Belldegrun · board

Reported raises · per SEC filings

Form D private placements

$378.4M disclosed across 6 rounds · 2019–2025

▶$95.5MraisedMay 2026 · 46 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Raphael WallanderDirector
  • Niall MullaneExecutive Officer
  • Hemi ZuckerDirector
  • Amy SchulmanDirector
  • Elizabeth AbramsDirector
  • Tommy BurkeDirector
  • Georg Krause-VilmarExecutive Officer
  • Arie BelldegrunDirector
  • Mia B. FuntExecutive Officer, Director
  • Devon KuehnExecutive Officer
  • Anton LinderumDirector
  • Ron BelldegrunExecutive Officer, Director
  • Joshua BradleyDirector
  • Denice TorresDirector
  • Joshua KazamDirector
  • Guy OranimDirector
Offering amount
$95.5M
Amount sold
$95.5M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72.2MraisedMar 2026 · 49 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Georg Krause-VilmarExecutive Officer
  • Amy SchulmanDirector
  • Hemi ZuckerDirector
  • Guy OranimDirector
  • Arie BelldegrunDirector
  • Anton LinderumDirector
  • Joshua KazamDirector
  • Raphael WallanderDirector
  • Elizabeth AbramsDirector
  • Mia B. FuntExecutive Officer, Director
  • Tommy BurkeDirector
  • Niall MullaneExecutive Officer
  • Denice TorresDirector
  • Ron BelldegrunExecutive Officer, Director
  • Devon KuehnExecutive Officer
  • Joshua BradleyDirector
Offering amount
$173.1M
Amount sold
$72.2M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.6MraisedJan 2023 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron BelldegrunExecutive Officer, Director, Promoter
  • Robert PeruzziExecutive Officer
  • Joshua BradleyDirector
  • Joshua A. KazamDirector
  • Michael TullyDirector
  • Arie S. BelldegrunDirector
  • Mia B. FuntExecutive Officer, Director, Promoter
  • Devon KuehnExecutive Officer
  • Guy OranimDirector
  • Hemi ZuckerDirector
  • Amy SchulmanDirector
Offering amount
$60M
Amount sold
$29.6M
Proceeds to insiders
$2.2M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$62.2MraisedJul 2021 · 63 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua BradleyDirector
  • Saloni VarmaExecutive Officer
  • Amy SchulmanDirector
  • James E. BauersmithExecutive Officer
  • Arie S. BelldegrunDirector
  • Hemi ZuckerDirector
  • Michael TullyDirector
  • Guy OranimDirector
  • Mia B. FuntExecutive Officer, Director, Promoter
  • Ron BelldegrunExecutive Officer, Director, Promoter
  • Joshua A. KazamDirector
Offering amount
$90M
Amount sold
$62.2M
Proceeds to insiders
$1.4M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$96.9MraisedApr 2020 · 99 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Allan SebbagExecutive Officer
  • Joshua KazamDirector
  • Mia B. FuntExecutive Officer, Director, Promoter
  • Joshua BradleyDirector
  • Hemi ZuckerDirector
  • Amy SchulmanDirector
  • Arie S. BelldegrunDirector
  • James E. BauersmithExecutive Officer
  • Guy OranimDirector
  • Ron BelldegrunExecutive Officer, Director, Promoter
Offering amount
$102.1M
Amount sold
$96.9M
Proceeds to insiders
$1.4M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22MraisedJun 2019 · 49 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron BelldegrunExecutive Officer, Director, Promoter
  • Joshua KazamDirector
  • Guy OranimDirector
  • Mia B. FuntExecutive Officer, Director, Promoter
Offering amount
$22M
Amount sold
$22M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Baby List290 shared keywordsBabylist is an online baby registry and shopping platform that helps families register for baby gear and items.
Bobbie196 shared keywordsBobbie manufactures baby formula and builds workplace support for parents. The company serves parents and their families while advocating for changes in infant feeding practices.

Companies competing with ByHeart for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Baby Formula Company ByHeart Raises $72 Million in New Funding | Femtech Insiderfemtechinsider.com · Apr 2025What are Mission Vision & Core Values of ByHeart Company? – businessmodelcanvastemplate.combusinessmodelcanvastemplate.com · Nov 2024ByHeart Raises $95M in Fundingfinsmes.com · May 2024ByHeart Announces $95M in New Financing On The Heels of Rapid Growth and the Completion of its End-to-End Manufacturing, Furthering its Commitment to Transforming the Infant Formula Industryprnewswire.com · May 2024ByHeart Secures $90M Series B Financing and Achieves All of its Clinical Trial Endpointsprnewswire.com · Jul 2021Baby Nutrition Company ByHeart Raises $70 Millionpulse2.com · Apr 2020

Frequently asked questions

What does ByHeart do?
ByHeart is an infant formula company navigating an FDA return-to-market process following a product outbreak investigation. The page addresses regulatory findings, corrective actions, and manufacturing controls rather than describing the full product line.
Who founded ByHeart?
ByHeart was founded by Mia B. Funt, Ron Belldegrun, Mia Funt in 2017.
Who are ByHeart's investors?
ByHeart's investors include Evolution VC Partners, OCV Partners, Polaris Partners, Red Sea Ventures, Vida Ventures.
How much funding has ByHeart raised?
ByHeart has disclosed $378.4M raised across 6 rounds.
Where is ByHeart headquartered?
ByHeart is headquartered in New York, US.